Can TPS Expression Reliably Predict Treatment Outcomes and Survival in Nasopharyngeal Cancer?
Turkish Journal of Oncology · 2026 · 28-35
DOI: 10.5505/tjo.2026.4731 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Oncology, 2026. Verfasst von Tuğba YILMAZ und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Nasopharyngeal cancer (NPC) is highly treatment-sensitive, yet distant metastasis remains a challenge. Data on adjuvan therapy needs in non-metastatic (NM) cases from non-endemic regions (NERs) are limited. This retrospective cohort analysis aimed to evaluate the prognostic impact of PD-L1 and Tumor Proportion Score (TPS) in NM NPC patients from a NER.
Zitieren
APA
YILMAZ, T., KANYILMAZ, G., FINDIK, S., & AYÇİÇEK, S. T. (2026). Can TPS Expression Reliably Predict Treatment Outcomes and Survival in Nasopharyngeal Cancer?. Turkish Journal of Oncology, 28-35. https://doi.org/10.5505/tjo.2026.4731
Vancouver
YILMAZ T, KANYILMAZ G, FINDIK S, AYÇİÇEK ST. Can TPS Expression Reliably Predict Treatment Outcomes and Survival in Nasopharyngeal Cancer?. Turkish Journal of Oncology. 2026:28-35. doi:10.5505/tjo.2026.4731
BibTeX
@article{YILMAZ2026,
author = {YILMAZ, Tuğba and KANYILMAZ, Gül and FINDIK, Sıdıka and AYÇİÇEK, Seda TAS},
title = {Can TPS Expression Reliably Predict Treatment Outcomes and Survival in Nasopharyngeal Cancer?},
journal = {Turkish Journal of Oncology},
year = {2026},
pages = {28--35},
doi = {10.5505/tjo.2026.4731}
}
EUVIMED